Softwr

Healthcare · head to head

Ginger vs PathAI

Ginger logo

Ginger

Healthcare

Digital mental health platform with coaching and therapy

From
On request
Rated
-
Full reviewWebsite
PathAI logo

PathAI

Healthcare

Digital pathology image management with an FDA cleared platform for primary diagnosis

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Ginger no longer sold as Ginger. It is part of Headspace, and ginger.com redirects to the Headspace organizations site; PathAI aISight is labelled research use only and cannot be used for primary diagnosis; only AISight Dx carries the FDA clearance and CE-IVD mark, and laboratories regularly buy the wrong configuration and discover they cannot sign out on it.
  • They diverge on capability: Ginger covers Mental Health Coaching, PathAI covers AISight image management.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Ginger and PathAI actually diverge.

Attributes where Ginger and PathAI differ
AttributeGingerPathAI
Pricing modelsubscriptionquote
PlatformsWeb, MobileWeb
Founded2012Unknown

Identical on both: starting price (On request), free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Ginger

  • Mental Health Coaching
  • Therapy
  • Psychiatry
  • Meditation
  • Crisis Support
  • Wellness Content
  • Health Plans
  • Employers

Only in PathAI

  • AISight image management
  • AISight Dx
  • Scanner interoperability
  • Case and worklist management
  • AI algorithm deployment
  • Biopharmaceutical research tooling
  • LIS integration

What people use each for

The jobs each tool is most often brought in to do.

Ginger

  • Employer-funded mental health coaching for staffnot PathAI
  • Therapy and psychiatry access through an employee benefitnot PathAI
  • Self-guided meditation and sleep content alongside clinical carenot PathAI
  • Workplace mental health workshopsnot PathAI

PathAI

  • An academic medical centre going digital for primary diagnosis that needs the FDA cleared AISight Dx configuration rather than the research labelled versionnot Ginger
  • A reference laboratory consolidating subspecialty sign out across sites so a specialist pathologist can read cases from any locationnot Ginger
  • A pharmaceutical company needing consistent quantitative scoring of trial biopsies across many sites and readersnot Ginger
  • A laboratory with a mixed scanner estate that needs one image management layer rather than each scanner vendor viewernot Ginger

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Ginger

  • No longer sold as Ginger. It is part of Headspace, and ginger.com redirects to the Headspace organizations site
  • Bought by employers, health plans and consultants rather than by individuals
  • Pricing is not published

PathAI

  • AISight is labelled research use only and cannot be used for primary diagnosis; only AISight Dx carries the FDA clearance and CE-IVD mark, and laboratories regularly buy the wrong configuration and discover they cannot sign out on it.
  • The software licence is usually the smallest line in a digital pathology project, behind scanners, storage and network capacity, so a business case built around the software cost understates the real investment by a wide margin.
  • Whole slide images are very large, so a laboratory that does not model storage growth and retention policy from the start faces storage costs that grow faster than case volume and dominate the renewal.
  • Clinical validation is required per subspecialty rather than once for the platform, which means dermatopathology, gastrointestinal and breast each need their own concordance study and pathologist time before go live.
  • PathAI competes against pathology incumbents that also sell the scanners, and a laboratory buying an independent image management layer takes on the integration risk between scanner vendor and software vendor itself.

Pricing, plan by plan

Ginger

On request

No published plan breakdown. See the Ginger review.

PathAI

On request
  • AISight$undefined/year
    • Priced by annual slide or case volume and by pathologist seats
    • AISight Dx, the clinically cleared configuration, quoted separately from research use AISight
    • Image storage priced by capacity and retention policy

Which should you pick?

Choose Ginger if

  • You need mental health coaching.
  • You work on Web, Mobile.
  • You also want therapy.
Ginger review

Choose PathAI if

  • You need aisight image management.
  • You also want aisight dx.
PathAI review

Questions people ask

Is Ginger or PathAI better?
Neither clearly leads. Ginger starts at On request and PathAI at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Ginger or PathAI?
Ginger starts at On request and PathAI at On request.
Does Ginger or PathAI run on more platforms?
Ginger runs on Web, Mobile. PathAI runs on Web.
What is Ginger best used for?
Ginger is most often used for employer-funded mental health coaching for staff, therapy and psychiatry access through an employee benefit, self-guided meditation and sleep content alongside clinical care, workplace mental health workshops. Of those, employer-funded mental health coaching for staff and therapy and psychiatry access through an employee benefit are not what PathAI is typically brought in for.
What can Ginger do that PathAI cannot?
Ginger covers Mental Health Coaching, Therapy, Psychiatry, Meditation. PathAI covers AISight image management, AISight Dx, Scanner interoperability, Case and worklist management.

Answered from the vendors’ own pages

Ginger: How is Headspace for Organizations priced?

Headspace for Organizations uses a custom pricing model based on company size, employee count, and specific services needed. Detailed pricing is not available on the public website.

Source
PathAI: What is the difference between AISight and AISight Dx?

AISight is for research use only and not for clinical diagnostic use. AISight Dx received FDA 510(k) clearance in June 2025 for primary diagnosis and is CE-IVD marked in the EEA, UK and Switzerland. Only the Dx configuration can be used to sign out cases.

Ginger: Do you offer a trial for Headspace for Organizations?

To learn about trial availability, you must request a demo through the website or contact Headspace directly at [email protected].

Source
PathAI: Can we use our existing scanners?

Yes. AISight is designed to ingest images from multiple whole slide scanner vendors, which is one of the main reasons laboratories choose an independent image management layer.

Ginger: What services are included in Headspace for Organizations?

Headspace for Organizations includes EAP (Employee Assistance Program), Care services, coaching, therapy, and psychiatry support, though specific features included at each pricing level are not detailed on the website.

Source
PathAI: Do the AI algorithms carry the same clearance as the platform?

No. The platform clearance covers image management for primary diagnosis. Individual algorithms have their own labelling, and many are research use only. Check each one separately.

PathAI: Is pricing published?

No. It is quoted by slide or case volume, pathologist seats and storage, with the clinically cleared configuration priced separately.

Share

Related pages

More on Ginger

More on PathAI

Keep looking

Other head to heads